Discover
Visualize rapid, validated insights through real-world data.
Aetion has entered into an agreement to be acquired by Datavant, a leading health data platform company. Learn more →
Real-world evidence (RWE) is transforming how MedTech companies demonstrate product value, improve patient outcomes, and accelerate innovation. Through our platform and scientific services, we partner with you to:
Aetion partners with MedTech industry leaders to drive scalable RWE excellence through strategic partnerships and proven frameworks.
Aetion collaborates with NESTcc and the US Food and Drug Administration's (FDA) Center for Devices and Radiologic Health (CDRH) to generate regulatory-grade RWE for label updates and expansions for medical devices and diagnostics.
How our strategic partnerships and scientific solutions drive real-world results.
Through their strategic partnership, the National Evaluation System for Health Technology Coordinating Center (NESTcc) and Aetion, along with the FDA’s Center for Devices and Radiological Health (CDRH), are on a mission to advance the use of RWE in the medical device and diagnostic ecosystem.
“The Aetion team delivered best in class thought leadership and content in how RWE studies should be designed across the product life cycle and drove great engagement amongst the participants. Aetion was able to balance the complex “theoretical principles” behind RWE, which can be overwhelming and complex, with this company's diverse product portfolio and evidence generation needs.”
Top 15 Medical Device Company, on Aetion-led workshops advancing RWE across business units
Aetion offers generous benefits to its full-time employees, which currently can include:
The benefits offering may differ based on geographies where employees are based, when outside of the United States.
Label expansion powered by RWE is creating seismic change across the MedTech industry by accelerating timelines and unlocking new value from existing products.
Aetion brings deep regulatory expertise and scientific rigor to support label expansion submissions with RWE.
Aetion recently partnered with FDA, NEST, and Intuitive to successfully support a product labeling modification using fit-for-purpose real-world data. Read the full press release ->Medical device manufacturers are required by the European Union (EU) Medical Device Regulation (MDR) to conduct Post-Market Clinical Follow-up (PMCF) analyses to assess the safety and performance of their products when used as intended. Through its scientific and platform offerings, Aetion:
Connect with us to work with the team advancing critical decisions in healthcare.